Media
News
Ein Ehemaliger will es wissen

Quotient Das Startup bringt den ersten in der Schweiz  produzierten Antikörpertest  auf den Markt. Dahinter steckt ein Ex-Roche-Manager.

Quotient Limited and hVIVO Announce Partnership to Support Wide-Spread COVID-19 Antibody Testing in the UK

JERSEY, Channel Islands, May 11, 2020 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, headquartered in Eysins, Switzerland, and hVIVO, part of Open Orphan plc (LONDON:ORPH), today announced that the MosaiQ™ by Quotient system and MosaiQ

Quotient CEO Franz Walt on talkRADIO with Mike Graham

Quotient CEO Franz Walt was interviewed on 05 May 2020 by Mike Graham on talkRADIO. They discussed the recently CE marked MosaiQ COVID-19 Antibody microarray, antibody testing, and the global COVID-19 pandemic. 

 

Quotient Limited Announces CE Mark for its SARS-CoV-2 (COVID-19) Antibody Microarray

JERSEY, Channel Islands, 1 May, 2020 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company (the Company), headquartered in Eysins, Switzerland, today announced that it has completed the process for declaring conformity to the essential requirements of the In V

Quotient Limited Announces SARS-CoV-2 (COVID-19) Antibody Test Final Performance Data

JERSEY, Channel Islands, April 27, 2020 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company (the Company), headquartered in Eysins, Switzerland, today reported very strong final study performance data for its SARS-CoV-2 antibody test.

Quotient Limited Announces SARS-CoV-2 (COVID-19) Antibody Test Performance Update

JERSEY, Channel Islands, April 21, 2020 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company (the Company), headquartered in Eysins, Switzerland, today reported positive performance data for its SARS-CoV-2 antibody test.

The Times UK: Antibody tests and 'mass diagnosis'

Mass diagnosis ‘available now’

CNN Money CH: Swiss company races to bring COVID-19 antibody tests to market

Experts say antibody testing will play a crucial role in easing coronavirus lockdowns around the world and reviving economies.

Financial Times: Swiss group says its machines can conduct 30m virus antibody tests this year

Quotient warns global shortages of critical components could hamper efforts

To read the full article, visit: Financial Times

Quotient Limited Announces the Completion of the SARS-CoV-2 Antibody Test Development

JERSEY, Channel Islands, April 06, 2020 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company (the Company), headquartered in Eysins, Switzerland, today announced the completion of the development phase of a microarray based SARS-CoV-2 (COVID-1